Skin cancer incidence in young adults declines: The risk of skin cancer, malignant melanoma, now appears to be decreasing in Sweden in those under 50

Read Full Article

#SkinCancer #YoungAdults #MalignantMelanoma #Sweden #HealthTrends

A topical cream activated the skin’s immune defenses and suppressed tumor growth in two preclinical models of cutaneous squamous cell carcinoma (cSCC), one of the most common cancers in the world

Read Full Article

#SkinCancer #Immunotherapy #cSCC

🔬 New experimental cream shows promise in preclinical studies to prevent or slow the growth of certain common skin cancers, specifically cutaneous squamous cell carcinoma (cSCC).

🛡️ The cream works by blocking an enzyme called LSD1, which normally suppresses the skin's immune defenses. By blocking LSD1, the cream activates the immune system to attack tumors.

📅 Researchers at the Perelman School of Medicine at the University of Pennsylvania are refining the cream's formula and aim to begin a phase 1 clinical trial within the next 1-2 years.

#SkinCancer #MedicalResearch #CancerTreatment